RVTY
Revvity Inc.
NYSE: RVTY · HEALTHCARE · DIAGNOSTICS & RESEARCH
$99.09
+7.36% today
Updated 2026-05-06
Market cap
$9.69B
P/E ratio
42.08
P/S ratio
3.39x
EPS (TTM)
$2.06
Dividend yield
0.32%
52W range
$81 – $118
Volume
1.1M
Revvity Inc. (RVTY) Financial Forecast & Price Target 2030
Revenue-driven projection model with historical context.
Price target summary
Current price
$99.09
12-Month target
$61.88
2030 Target
—
Intrinsic (DCF)
$109.59
Financial forecast
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 | 2027 (E) | 2028 (E) | 2029 (E) | 2030 (E) |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | $3.8B | $3.3B | $2.8B | $2.8B | $2.9B | $2.7B | $2.6B | $2.4B | $2.3B |
| EPS | — | — | — | — | — | — | — | — | — |
CAGR applied: -5.47% (capped 20%) · P/E: 25.00x (capped 25x) · Margin: 8.45%
Methodology
CAGR-based projection model. Research-backed estimates are being generated — check back soon for analyst consensus and management guidance.